|
(MoneyNewsWire.Net, December 22, 2017 ) According to the report North America Antivenom Market, published by Market Data Forecast, the market is projected to reach USD 542.4 million by 2021, at a CAGR of 4.87% from 2016 to 2021.
Antivenom is a medication used to treat bites of insects and animals which contain venom. They consist of antibodies collected by a domestic animal after injecting the venom into it. The antivenom needed is very specific to the species responsible for the bite or string. Antivenoms are only recommended if the toxicity levels are significant as their usage includes side effects such as serum sickness and shortness of breath.
In case of venomous snake bites, antivenoms are the only treatment to prevent or reverse most of the toxic effects of the venom. They reduce the risk of death in most cases. Venomous snake bites can cause paralysis that may prevent breathing, kidney failures which can be irreversible and local tissue destruction. It is very important to have the knowledge of poisonous species in a region so that the appropriate antivenom can be used for treatment.
Get a comprehensive overview of the North America Antivenom Market: http://www.marketdataforecast.com/market-reports/north-america-antivenom-market-1581/
North America Antivenom Market: Drivers and Restraints
Establishment of new snake poison control centres, increasing approval rate of antivenom products, increasing R&D for effective antivenom products, rising number of clinical trial centres to study antivenom products, and presence of healthcare centres are driving the growth of North America Antivenom Market. However, stringent regulations and cost pertaining to manufacturing of antivenom products are expected to restrain the growth of North America Antivenom Market.
Get accurate market forecast and analysis on the North America Antivenom Market. Request a sample to stay up-to-date on the main trends affecting this market: http://www.marketdataforecast.com/market-reports/north-america-antivenom-market-1581/request-sample
North America Antivenom Market: Segmentation
By Type:
Vaccines
Hyperimmune Sera
o Homologous
o Heterologous
By Animal
Snakes
Scorpions
Spiders
Others
From simple data collation through secondary and primary research to ad-hoc research requests relating to specific information, we provide our services via customization. Get customization at: http://www.marketdataforecast.com/market-reports/north-america-antivenom-market-1581/customize-report
North America Antivenom Market: Overview
Most of the antivenoms only function is to neutralize the venom but does not reverse the damage done to the body. Hence they should be given as soon as possible to prevent extensive damage which can lead to death. Antivenoms manufactured should meet the standards of World Health Organization and pharmacopoeia. According to an estimate, approximately 3000-8000 people are annually recorded in North America region.
Hence, antivenoms for snakes hold the largest market share in North America. Vaccines are not popular for antivenoms as nobody knows which animal might bite them and hence Hyperimmune Sera leads the market.
North America Antivenom Market: Region-wise Outlook
Based on geography the North America market is analyzed under various countries namely, USA and Canada. USA is leading the regions market in terms of revenue followed by Canada. It is due to the highly developed healthcare system available in USA.
Key Questions Answered:
What is the current and future Antivenom Market outlook in North America? What trends are affecting the North America market?
What is the competitive landscape and market share of major players in the Antivenom market in North America?
What are the key, high growth markets that Antivenom manufacturers should expand into? Which market segments are growing the fastest?
What are the unmet needs with the Antivenom currently on the market? How will emerging products fulfill these unmet needs?
What is physician perception and market outlook of Antivenom?
What are the challenges and barriers that have hindered widespread adoption of Antivenom?
North America Antivenom Market: Key Players
Major players in this market are Instituto Bioclon, S.A. de C.V. (Mexico), Pfizer AG (Switzerland), CSL Limited (Australia), F. Hoffmann-La Roche Ltd. (Switzerland), Merck & Co., Inc. (U.S.), Rare Disease Therapeutics, Inc. (U.S.), Vins Bioproducts Limited (India), BTG Plc (U.K.), Incepta Vaccine Ltd. (Bangladesh), and Bharat Serum and Vaccines Limited (BSV) (India)..
Reasons to buy North America Antivenom Market report:
Regional and country-level analysis and forecasts of the study market; providing Insights on the geographical areas in which this industry is prospering
Segment-level analysis on basis of product type, application, colour along with market size forecasts and y-o-y estimations to detect key areas of industry growth in detail
Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
Study of macro and micro environmental factors that affect the market presented in an extensive strategic analyses section containing PESTLE and Porters Five Forces Analyses
A comprehensive listing of key market players along with company overview, product portfolios, key financial information (subjected to availability), SWOT analysis and Analyst overview to study and sustain the market environment
Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
Expertly devised Market Outlook along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market.
Check out other related studies in the Pharmaceuticals Segment:
1. Antivenom Market: http://www.marketdataforecast.com/market-reports/global-antivenom-market-1580/
2. North America Bleeding Disorders Treatment Market: http://www.marketdataforecast.com/market-reports/north-america-bleeding-disorders-treatment-market-3362/
3. North America PEGylated Proteins Market: http://www.marketdataforecast.com/market-reports/north-america-pegylated-proteins-market-3356/
About Market Data Forecast:
Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, they cater to the needs of both individual and corporate clients. From all-encompassing umbrella markets to extremely specific niche markets covering all the major regions across the globe as part of the research scope, their research services offer one of a kind specialties with competitive pricing options.
For more information, kindly visit, www.marketdataforecast.com
Visit Market Data Forecast Blog @ http://www.marketdataforecast.com/blog/
View latest Press Releases of MDF @ http://www.marketdataforecast.com/press-releases
Market Data Forecast
Abhishek
+1-888- 702-9626
abhishek@marketdataforecast.com
Source: EmailWire.Com 
|
